|
GB0502277D0
|
|
Novel imaging agents
|
|
GB0427392D0
|
|
Stabilised 99mTc compositions
|
|
GB0425501D0
|
|
Fluoridation process
|
|
GB0422004D0
|
|
Method of deprotection
|
|
GB0421987D0
|
|
Novel technetium and rhenium complexes
|
|
GB0421308D0
|
|
Enzyme inhibitor imaging agents
|
|
GB0420344D0
|
|
Diagnostic compounds
|
|
GB0416062D0
|
|
Improved N4 chelator conjugates
|
|
GB0407952D0
|
|
Fluoridation method
|
|
GB0329812D0
|
|
Romp polymer synthesis
|
|
GB0329716D0
|
|
Radical trap
|
|
GB0327494D0
|
|
Novel imaging agents
|
|
GB0326546D0
|
|
Inhibitor imaging agents
|
|
GB0317920D0
|
|
Solid-phase synthesis
|
|
GB0308407D0
|
|
Method of obtaining 68 GA
|
|
GB0308408D0
|
|
Microwave activation
|
|
GB0307524D0
|
|
Diagnostic imaging agents with MMP inhibitory activity
|
|
GB0305704D0
|
|
Radiofluorination methods
|
|
EP1474178A1
|
|
Benzothiazole derivatives for in vivo imaging of amyloid plaques
|
|
GB0302891D0
|
|
Diagnostic imaging agents for cardiovascular disease
|
